Manufacturing Changes. BIONICHE may implement commercially reasonable changes in the equipment used for Manufacturing of the Drug Product in the Facility, or the Manufacturing methods, labeling, or packaging of the Drug Product only as expressly provided in the Specifications unless BIONICHE has the prior written consent of CUMBERLAND, which consent shall not be unreasonably withheld or delayed.
Appears in 3 contracts
Sources: Manufacturing Agreement (Cumberland Pharmaceuticals Inc), Manufacturing Agreement (Cumberland Pharmaceuticals Inc), Manufacturing Agreement (Cumberland Pharmaceuticals Inc)